As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq rules for the purchase and sale of an ...

BioNano Genomics ( (BNGO) ) has shared an update. Bionano Genomics announced a $3 million registered direct offering involving the sale of ...

Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 9,881,113 shares of its common ...

Applied DNA Sciences (APDN) announces $6.5M public offering and private placement. Shares fall 38% in premarket trading.

On Monday, BioNano Genomics Inc (BNGO) stock saw a modest uptick, ending the day at $0.31 which represents no change from the prior close of of $0.31. The stock opened at $0.31 and touched a low of $0 ...

BioNano Genomics Inc does not currently pay a dividend. AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for each of five key investing factors: value, growth, ...

The stock’s current closing high is $138.07, hit on Monday, but Nvidia ended at $136.93 on Thursday. Emily Bary is a MarketWatch news editor based in New York.

Bionano Genomics (BNGO) announced the publication in Blood Cancer Journal by a group of researchers at the Korea College of Medicine in South ...

On Wednesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.29 which represents a decrease of $-0.02 or -6.45% from the prior close of $0.31. The stock opened at $0.31 and ...